Somatic STAT3 mutations in large granular lymphocytic leukemia

New England Journal of Medicine

Volumn 366, Issue 20, 2012, Pages 1905-1913

  Koskela, Hanna L M ^a   Eldfors, Samuli ^a   Ellonen, Pekka ^a   Van Adrichem, Arjan J ^a   Kuusanmäki, Heikki ^a   Andersson, Emma I ^a   Lagström, Sonja ^a   Clemente, Michael J ^e   Olson, Thomas ^f   Jalkanen, Sari E ^a   Majumder, Muntasir Mamun ^a   Almusa, Henrikki ^a   Edgren, Henrik ^a   Lepistö, Maija ^a   Mattila, Pirkko ^a,b   Guinta, Kathryn ^e   Koistinen, Pirjo ^c   Kuittinen, Taru ^d   Penttinen, Kati ^a   Parsons, Alun ^a   Knowles, Jonathan ^a   Saarela, Janna ^a   Wennerberg, Krister ^a   Kallioniemi, Olli ^a   Porkka, Kimmo ^a   Loughran, Thomas P ^f   Heckman, Caroline A ^a   Maciejewski, Jaroslaw P ^e   Mustjoki, Satu ^a   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e TAUSSIG CANCER INSTITUTE   (United States)

^f PENN STATE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; BCL2L1 GENE; CD8+ T LYMPHOCYTE; CELL NUCLEUS; COHORT ANALYSIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIMERIZATION; EXOME; EXON; GENE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IFNGR2 GENE; IN VITRO STUDY; JAK2 GENE; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEUTROPENIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 GENE; SOMATIC MUTATION; UPREGULATION;

EID: 84861023172     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1114885     Document Type: Article

References (35)

1. Loughran TP Jr, Kadin ME, Starkebaum G, et al. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 1985;102:169-75. (Pubitemid 15157163)
2. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
3. Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist 2006;11:263-73.
4. Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 2006;20:245-66. (Pubitemid 44209204)
5. Rossi D, Franceschetti S, Capello D, et al. Transient monoclonal expansion of CD8+/CD57+ T-cell large granular lymphocytes after primary cytomegalovirus infection. Am J Hematol 2007;82:1103-5. (Pubitemid 350209855)
6. Gentile TC, Hadlock KG, Uner AH, et al. Large granular lymphocyte leukaemia occurring after renal transplantation. Br J Haematol 1998;101:507-12. (Pubitemid 28266946)
7. Mohty M, Faucher C, Vey N, et al. Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis. Leukemia 2002;16:2129-33. (Pubitemid 35203458)
8. Mustjoki S, Ekblom M, Arstila TP, et al. Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia 2009;23:1398-405.
9. Clemente MJ, Wlodarski MW, Makishima H, et al. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood 2011;118:4384-93.
10. Zhang R, Shah MV, Yang J, et al. Network model of survival signaling in large granular lymphocyte leukemia. Proc Natl Acad Sci U S A 2008;105:16308-13.
11. Shah MV, Zhang R, Irby R, et al. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood 2008;112:770-81.
12. Epling-Burnette PK, Bai F, Wei S, et al. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 2004;23:9220-9. (Pubitemid 40069692)
13. Schade AE, Powers JJ, Wlodarski MW, Maciejewski JP. Phosphatidylinositol- 3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 2006;107:4834-40. (Pubitemid 43882635)
14. Schade AE, Wlodarski MW, Maciejewski JP. Pathophysiology defined by altered signal transduction pathways: the role of JAK-STAT and PI3K signaling in leukemic large granular lymphocytes. Cell Cycle 2006;5:2571-4. (Pubitemid 44785798)
15. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008;456:66-72.
16. Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009;361:1058-66.
17. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med 2011;364:2305-15.
18. Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011;365:1384-95.
19. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011;365:2497-506.
20. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell 1999; 98:295-303. [Erratum, Cell 1999;99:239.] (Pubitemid 29380565)
21. Pilati C, Amessou M, Bihl MP, et al. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med 2011;208:1359-66.
22. Scarzello AJ, Romero-Weaver AL, Maher SG, et al. A mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis. Mol Biol Cell 2007;18:2455-62. (Pubitemid 47025711)
23. Becker S, Groner B, Müller CW. Three-dimensional structure of the Stat-3beta homodimer bound to DNA. Nature 1998;394:145-51. (Pubitemid 28325960)
24. Epling-Burnette PK, Liu JH, Catlett- Falcone R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001;107:351-62.
25. Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 1998;161:4652-60. (Pubitemid 28492039)
26. Haga S, Terui K, Zhang HQ, et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003;112:989-98. (Pubitemid 38056314)
27. Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TP Jr. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998;92:4771-7. (Pubitemid 29005880)
28. Yang J, Epling-Burnette PK, Painter JS, et al. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 2008;111:1610-6. (Pubitemid 351213452)
29. Hayakawa F, Sugimoto K, Kurahashi S, Sumida T, Naoe T. A novel STAT3 inhibitor OPB-31121 induces tumor-specific growth inhibition in a wide range of hematopoietic malignancies without growth suppression of normal hematopoietic cells. In: Program and abstracts of the 53rd American Society of Hematology annual meeting and exposition, San Diego, CA, December 10-13, 2011. abstract.
30. Liu JH, Wei S, Lamy T, et al. Chronic neutropenia mediated by Fas ligand. Blood 2000;95:3219-22. (Pubitemid 30321177)
31. Kothapalli R, Nyland SB, Kusmartseva I, Bailey RD, McKeown TM, Loughran TP Jr. Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia. Int J Oncol 2005;26:529-35.
32. Chen X, Bai F, Sokol L, et al. A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia. Blood 2009;113:3226-34.
33. Wang F, Sengupta TK, Zhong Z, Ivashkiv LB. Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids. J Exp Med 1995;182:1825-31.
34. Ramos HL, Valencia-Pacheco G, Alcocer-Varela J. Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjögren's syndrome. Scand J Rheumatol 2008;37:35-9.
35. Lovato P, Brender C, Agnholt J, et al. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. J Biol Chem 2003;278:16777-81. (Pubitemid 36799545)